Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3100 of 3546 entries
View as:

A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT04398745 Org: User:
Start: 10/09/20 End: 12/31/25 Due: 12/31/26

A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.

Phase: N/A Priority: Normal
NCT ID: NCT00500201 Org: User:
Start: 05/24/07 End: 07/25/07 Due: 07/25/08

A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00866580 Org: User:
Start: 05/31/10 End: 07/31/11 Due: 07/31/12

Drug Utilization Study for Pirinase Hayfever Relief

Phase: N/A Priority: Normal
NCT ID: NCT02856282 Org: User:
Start: 02/15/16 End: 03/31/18 Due: 03/31/19

A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

Phase: N/A Priority: Normal
NCT ID: NCT02858440 Org: User:
Start: 09/13/16 End: 11/13/18 Due: 11/13/19

Effect of Two Toothpastes on Bacteria in Saliva

Phase: N/A Priority: Normal
NCT ID: NCT03587428 Org: User:
Start: 11/04/14 End: 11/27/14 Due: 11/27/15

A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01879462 Org: User:
Start: 06/14/13 End: 01/10/14 Due: 01/10/15

Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05791565 Org: User:
Start: 04/03/23 End: 05/21/23 Due: 05/21/24

Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

Phase: N/A Priority: Normal
NCT ID: NCT01551537 Org: User:
Start: 04/30/13 End: 04/30/14 Due: 04/30/15

Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations

Phase: N/A Priority: Normal
NCT ID: NCT00633074 Org: User:
Start: 03/03/08 End: 04/11/08 Due: 04/11/09

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

Phase: N/A Priority: Normal
NCT ID: NCT02251704 Org: User:
Start: 10/22/14 End: 07/06/24 Due: 07/06/25

Comparing Two Respiratory Drugs in Combination and Separately From a Novel Inhaler Device in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00625196 Org: User:
Start: 02/27/08 End: 05/06/08 Due: 05/06/09

INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design

Phase: N/A Priority: Normal
NCT ID: NCT03467425 Org: User:
Start: 04/11/18 End: 10/10/19 Due: 10/10/20

Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT02052596 Org: User:
Start: 02/07/14 End: 04/21/16 Due: 04/21/17

To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02195284 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females

Phase: N/A Priority: Normal
NCT ID: NCT00651534 Org: User:
Start: 02/29/08 End: - Due: -

A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00460707 Org: User:
Start: 04/16/07 End: 08/27/07 Due: 08/27/08

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01916226 Org: User:
Start: 08/01/13 End: 10/17/13 Due: 10/17/14

This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01706315 Org: User:
Start: 10/17/12 End: 12/13/13 Due: 12/13/14

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00425737 Org: User:
Start: 08/31/00 End: 07/31/01 Due: 07/31/02

Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00347919 Org: User:
Start: 07/31/06 End: 03/31/15 Due: 03/31/16

Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)

Phase: N/A Priority: Normal
NCT ID: NCT01277042 Org: User:
Start: 02/17/11 End: 02/28/12 Due: 02/28/13

Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02705807 Org: User:
Start: 05/31/16 End: 07/31/16 Due: 07/31/17

Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib

Phase: N/A Priority: Normal
NCT ID: NCT02314143 Org: User:
Start: 11/13/13 End: 01/19/17 Due: 01/19/18

Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™

Phase: N/A Priority: Normal
NCT ID: NCT01641133 Org: User:
Start: 09/04/12 End: 05/07/14 Due: 05/07/15